Browsing by Author BECKER K.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2000JRC19821Binding of a Bi-213 Labeled Monoclonal Antibody Targeting a Tumor Specific Mutant E-Cadherin in Different Tumor Models.ADAM C.; SCHUHMACHER C.; BECKER K.; HANDSCHUH G.; NIKULA T.; APOSTOLIDIS Christos; FISCHER K.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2002JRC24651The ECVAM International Validation Study on in vitro Embryotoxicity Tests. Results of the Definite Phase and Evaluation of Prediction Models.GENSCHOW E.; SPIELMANN Horst; SCHOLZ G.; SEILER A.; BROWN Nigel; PIERSMA Aldert; BRADY Madelaine; CLEMANN N.; HUUSKONEN H.; PAILLARD F., et alArticles in Journals
2001JRC21246Highly Specific Tumor Binding of a 213Bi Labeled Monoclonal Antibody against Mutant E-Cadherin Suggests its Usefulness for Locoregional alpha-Radioimmunotherapy of Diffuse-Type Gastric Cancer.SENEKOWITSCH-SCHMIDTKE R.; SCHUHMACHER C.; BECKER K.; NIKULA T.k.; SEIDL C.; BECKER I.; MIEDERER M.; APOSTOLIDIS Christos; ADAM C.; HUBER Roswitha, et alArticles in Journals
2001JRC22091Preliminary Results of the ECVAM Validation Study on Three in vitro.SPIELMANN Horst; GENSCHOW E.; SCHOLZ G.; BROWN Nigel; PIERSMA Aldert; BRADY Madelaine; CLEMANN N.; HUUSKONEN H.; PAILLARD F.; BREMER Suzanne, et alArticles in Journals
2000JRC21180Tumor Binding and Therapeutic Efficacy of 213-Bi Labeled Mutation Specific Monoclonal Antobody in a Human Intraperitoneal Gastric Cancer Model.SENEKOWITSCH-SCHMIDTKE R.; FISCHER K.; SCHUMACHER C.; BECKER I.; BECKER K.; APOSTOLIDIS Christos; NIKULA T.; SCHWAIGER M.Contributions to Conferences
2004JRC26148Validation of the Embryonic Stem Cell Test (EST) in the International ECVAM Validation Study of three in vitro Embryotoxicity Tests.GENSCHOW E.; SPIELMANN Horst; SCHOLZ G.; POHL I.; SEILER A.; CLEMANN N.; BREMER S.; BECKER K.Articles in Journals